IL6 and cancer: Being a classical member of the IL-6 cytokine family, it was originally discovered as BSF-2 to elicit antibody production and control acute phase protein generation [14] It has also evolved as a key player in modulating cancer cells through its transactivation via STAT3 mechanisms, which constitutively express IL-6 and other chemokines important to the disease phenotype [15].